BT
EW icon

Banque Transatlantique’s Edwards Lifesciences EW Stock Holding History

Banque Transatlantique’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67M Sell
31,340
-616
-2% -$51.6K 0.06% 101
2026
Q1 		$2.57M Buy
31,956
+655
+2% +$54K 0.06% 86
2025
Q4 		$2.67M Sell
31,301
-6,133
-16% -$503K 0.06% 63
2025
Q3 		$2.91M Sell
37,434
-18,134
-33% -$1.42M 0.07% 61
2025
Q2 		$4.36M Sell
55,568
-3,319
-6% -$248K 0.12% 44
2025
Q1 		$4.26M Sell
58,887
-15,267
-21% -$1.09M 0.13% 45
2024
Q4 		$5.44M Buy
+74,154
New +$5.19M 0.14% 45

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Banque Transatlantique's EW Position: Q2 2026 in Review

Banque Transatlantique reduced its Edwards Lifesciences (EW) stake by 1.9% in Q2 2026, selling an estimated $51.6K and leaving 31,340 shares worth $2.67M. The position accounts for 0.06% of the portfolio, ranked #101.

Banque Transatlantique first reported a position in EW in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.44M in Q4 2024. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Banque Transatlantique held 31,340 shares of Edwards Lifesciences worth $2.67M as of Q2 2026.
  • Banque Transatlantique sold 616 Edwards Lifesciences shares in Q2 2026, an estimated $51.6K.
  • Edwards Lifesciences made up 0.06% of Banque Transatlantique's portfolio in Q2 2026, its #101 holding.
  • Banque Transatlantique first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's Edwards Lifesciences position peaked at $5.44M in Q4 2024.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.